National Institute for Health and Care Excellence
Asthma Management 2021
This guideline holds 52 pages.
Summary
Updated NICE asthma guidance endorses FeNO testing in the diagnostic pathway and recommends MART (Maintenance and Reliever Therapy) with ICS-formoterol as preferred treatment for adults with uncontrolled asthma on low-dose ICS. Removes SABA-only prescribing from first-line.
How the evidence was graded
Grading system
Class I–II
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- National Institute for Health and Care Excellence
- Published
- 2021
- Region
- UK
- Language
- English
- Grading system
- Class I–II
Keywords
- Asthma
- ICS
- MART therapy
- FeNO
- SABA
- Formoterol
More in pulmonology
- Comprehensive rehabilitation guideline for lung transplantationunknown · 2026
- The Diagnosis of Primary Ciliary Dyskinesia: Putting The European Respiratory/American Thoracic Guideline Into PracticeEuropean Respiratory Society / American Thoracic Society · 2026
- Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC
